Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients
  • +8
  • Jin-jin Zhang,
  • Yi-yuan Cao,
  • Ge Tan,
  • Xiang Dong,
  • Bin-chen Wang,
  • Jun Lin,
  • You-qin Yan,
  • Guanghui Liu,
  • Mubeccel Akdis,
  • Cezmi Akdis,
  • Ya-dong Gao
Jin-jin Zhang
Wuhan University Zhongnan Hospital

Corresponding Author:[email protected]

Author Profile
Yi-yuan Cao
Wuhan University Zhongnan Hospital Department of Radiology
Author Profile
Ge Tan
Swiss Institute of Allergy and Asthma Research
Author Profile
Xiang Dong
Wuhan University Zhongnan Hospital
Author Profile
Bin-chen Wang
Wuhan University Zhongnan Hospital
Author Profile
Jun Lin
Wuhan University Zhongnan Hospital
Author Profile
You-qin Yan
No. 7 Hospital of Wuhan
Author Profile
Guanghui Liu
Wuhan University Zhongnan Hospital
Author Profile
Mubeccel Akdis
University of Zürich
Author Profile
Cezmi Akdis
University of Zurich
Author Profile
Ya-dong Gao
Wuhan University Zhongnan Hospital
Author Profile

Abstract

Background Currently, the coronavirus disease 2019 (COVID-19) has become pandemic globally. 10-20% of the cases are severe and more than 397,000 deaths have occurred. The risk factors for the mortality of critically ill COVID-19 patients remain to be elucidated. Conclusions Survived severe and non-survived COVID-19 patients had distinct clinical and laboratory characteristics, which were separated by principle component analysis. Logistic regression revealed several risk factors such as elder age, greater affected lobe numbers and higher level of serum CRP for the mortality of severe COVID-19 patients. Longitudinal changes of laboratory findings indicate the advancement of the disease and may be helpful in predicting the progression of severe patients.
08 Jun 2020Submitted to Allergy
08 Jun 2020Submission Checks Completed
08 Jun 2020Assigned to Editor
09 Jun 2020Reviewer(s) Assigned
24 Jun 2020Review(s) Completed, Editorial Evaluation Pending
25 Jun 2020Editorial Decision: Revise Minor
07 Jul 20201st Revision Received
07 Jul 2020Submission Checks Completed
07 Jul 2020Assigned to Editor
07 Jul 2020Reviewer(s) Assigned
08 Jul 2020Review(s) Completed, Editorial Evaluation Pending
08 Jul 2020Editorial Decision: Accept
24 Aug 2020Published in Allergy. 10.1111/all.14496